Aprio Wealth Management’s GSK GSK Stock Holding History

Aprio Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$410K	Buy	7,814 +143	+2%	+$7.56K	0.02%	435
2026 Q1	$423K	Buy	7,671 +767	+11%	+$41.6K	0.02%	401
2025 Q4	$339K	Buy	+6,904	New	+$322K	0.02%	407
2025 Q2	–	Sell	-6,397	Closed	-$248K	–	420
2025 Q1	$248K	Buy	+6,397	New	+$234K	0.03%	311
2024 Q4	–	Sell	-4,933	Closed	-$202K	–	318
2024 Q3	$202K	Buy	+4,933	New	+$202K	0.03%	271

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Aprio Wealth Management's GSK Position: Q2 2026 in Review

Aprio Wealth Management increased its GSK (GSK) stake by 1.9% in Q2 2026, buying an estimated $7.56K and bringing the position to 7,814 shares worth $410K. The position accounts for 0.02% of the portfolio, ranked #435.

Aprio Wealth Management first reported a position in GSK in Q3 2024 and has held it in 5 quarters since. The position peaked at $423K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Aprio Wealth Management held 7,814 shares of GSK worth $410K as of Q2 2026.
Aprio Wealth Management bought 143 GSK shares in Q2 2026, an estimated $7.56K.
GSK made up 0.02% of Aprio Wealth Management's portfolio in Q2 2026, its #435 holding.
Aprio Wealth Management first reported a position in GSK in Q3 2024 and has held it in 5 quarters since.
Aprio Wealth Management's GSK position peaked at $423K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Aprio Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.